DGK Herztage 2019

Donnerstag, 10. Oktober 2019 (Posterbereich 13) 14:00-15:30

Poster

Ergebnisse der Cryo-PVF

Diskussionsleiter: J. W. Schrickel (Bonn), S. G. Spitzer (Dresden)

(P230) First-Year-Experience Using Cryoballoon for Pulmonary Vein Isolation in an Experienced Atrial Fibrillation Ablation Center: Acute Efficacy, Complications, and Effect on Work-Flow
    G. Borisov, S. Raffa, O. Alothman, G. D'Ambrosio, M. Frommhold, J. C. Geller (Bad Berka)
(P231) Ablation beyond “normal” pulmonary vein isolation: midterm results after left atrial roof ablation using the cryoballoon technique and its impact on left atrial function
    E. Akkaya, K. Sözener, A. Berkowitsch, A. Rieth, D. Erkapic, C. W. Hamm, T. Neumann, M. Kuniss (Siegen, Bad Nauheim, Gießen)
(P232) Feasibility, safety and acute efficacy of the fourth-generation cryoballoon for ablation of atrial fibrillation: Another step forward?
    L. Rottner, S. Mathew, B. Reissmann, C. Lemes, T. Maurer, P. Wohlmuth, F. Ouyang, K.-H. Kuck, A. Metzner, A. Rillig (Hamburg)
(P233) Extended long-term follow-up of radiofrequency catheter ablation for redo procedures after pulmonary vein isolation with the cryoballoon technique (first versus second generation cryoballoon)
    K. Kettering (Frankfurt am Main)
(P234) Two-year follow-up of a TTI-dependent Cryo-PVI ablation protocol – Can a 2-minute freeze be sufficient?
    D.-L. Federle, K. Weinmann, F. Glöckler, T. Stephan, K. Petscher, W. Rottbauer, T. Dahme, A. Pott (Ulm)
(P235) First clinical outcome data after pulmonary vein isolation with the 4th generation cryoballoon
    L. Piskorski, S. Jäck, C. Schweizer, K. Weinmann, C. Bothner, W. Rottbauer, A. Pott, T. Dahme (Ulm)
(P236) Lessons learned from premature termination of the freeze duration in patients undergoing pulmonary vein isolation with the cryoballoon: Have we reached the optimal freeze duration yet?
    C. Schweizer, S. Jäck, K. Weinmann, M. Rattka, T. Stephan, W. Rottbauer, T. Dahme, A. Pott, für die Studiengruppe: ATRIUM (Ulm)
(P237) Outcome of Cryoballoon versus Radiofrequency Ablation in symptomatic persistent Atrial Fibrillation – Subgroup analysis of the large prospective multicentre FREEZE Cohort Trial
    F. Straube, A. Metzner, M. Kuniss, R. R. Tilz, D. Andresen, L.-Q. Wu, C. Stellbrink, A. Garcia-Alberola, R. Gopal, J. W. Schrickel, A. Franke, U. Dorwarth, T. Ouarrak, K. Wegscheider, K. R. J. Chun, J. Brachmann, K.-H. Kuck, J. Senges, E. Hoffmann, für die Studiengruppe: FREEZE COHORT INVESTIGATORS (München, Hamburg, Bad Nauheim, Lübeck, Berlin, Bielefeld, Bonn, Hannover, Ludwigshafen am Rhein, Frankfurt am Main, Coburg; Shanghai, CN; El-Palmar Murcia, ES; Panorama - Cape Town, ZA)


16:30 - 17:00 Eröffnung des Kongresses und Preisverleihungen in Saal Berlin A